-
A new polygenic risk score (PRS) can be used to predict a woman’s risk of developing breast cancer, especially when it is used in conjunction with information about breast tissue density and family history. The PRS is described in […]
read more -
Certain types of mutation in specific parts of the BRCA1 and BRCA2 genes can alter the risk for breast or ovarian cancer, according to results from a study published in the April 7 issue of JAMA. “The study results […]
read more -
More than a third (37.1%) of cancer patients are “seriously or very seriously” concerned about bankrupcy because of medical bills, according to a survey sponsored by the international nonprofit Cancer Support Community (CSC). And 47.7% of the 480 respondents […]
read more -
About $4 billion is spent ever year in the United States because of false-positive mammography results and breast cancer overdiagnosis, according to a new study. In an analysis that involved more than 700,000 women 40 to 59 years of […]
read more -
A large percent of cancer patients use some form of complementary and alternative medicine (CAM), typically with the goal of relieving pain and controlling the adverse effects of disease or treatment. A new review of evidence drawn from experimental […]
read more -
Skin flap loss can be a devastating complication of breast reconstruction following mastectomy, but the use of intraoperative laser angiography using indocyanine green (ICG) can help prevent it through real-time assessment of tissue perfusion, according to a plastic surgeon who […]
read more -
Family history is a significant risk factor for breast cancer, especially in women who have first-degree relatives with the disease. That risk might be even higher if there is a first-degree relative with prostate cancer, a new study suggests. […]
read more -
SAN DIEGO, California — Breast cancer survivors are at increased risk of developing primary thyroid cancer compared with the general population, a new database analysis suggests. The findings were presented March 7 here at the annual meeting of the […]
read more -
What the science says: Determining whether a link between bisphenol A (BPA) and cancer exists has become increasingly important, given the ubiquity of this substance. BPA, which forms the building blocks of polycarbonate plastics and resins, has become one of […]
read more -
A statistically significant improvement in overall survival has been noted in a phase 3 trial in patients with advanced soft tissue sarcoma after treatment with eribulin (Halaven, Eisai) when compared with dacarbazine. The manufacturer says that it will submit […]
read more
